4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-25-020282
EVP, Corp Strategy & Develop sold 400 shares at $150.04 ($60,016)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2025-08-07 | Sale | −400 | $150.04 | $60,016 | 24,916 | D |
| Open-market sales · 400 sh · avg $150.04 · $60,016 | |||||||
Loading xslF345X05/form4.xml…